REMICADE is a tumor necrosis factor (TNF) blocker indicated for Crohn’s Disease, Pediatric Crohn’s Disease, Ulcerative Colitis, Pediatric Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Plaque Psoriasis.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of REMICADE (infliximab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the REMICADE (infliximab) medicine cost price in India.
The order for REMICADE (infliximab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Infliximab, a "chimeric monoclonal antibody", sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease.
REMICADE (infliximab) Lyophilized Concentrate for Injection, for Intravenous Use. Initial U.S. Approval: 1998
Generic Name: infliximab
100 mg of lyophilized infliximab in a 20 mL vial for intravenous infusion.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand REMICADE (infliximab) on prescription and Import License in Patient's Name only.
For overseas patients, REMICADE (infliximab) can be made available in Send your enquiry to find REMICADE (infliximab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For REMICADE (infliximab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details